Marica Eoli

12.1k citations
152 papers · 3.8k indexed · 2 hit papers · h-index 30

Impact in

  • Genetics top 0.2%
    • Glioma Diagnosis and Treatment
    • Cancer Genomics and Diagnostics
    • Cancer, Hypoxia, and Metabolism
    • MicroRNA in disease regulation

Papers in

    • Glioma Diagnosis and Treatment 86
    • Neurofibromatosis and Schwannoma Cases 21

Marica Eoli

146 papers receiving 3.8k citations

Hit Papers

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial 2018 · 257 citations
2572016202620192022100200300400

Peers

Marica Eoli
Comparison fields: 5 of 123
  • Genetics 2.0k
  • Cancer Research 766
  • Neurology 618
  • Pathology and Forensic Medicine 574
  • Oncology 693
Replace Joon H. Uhm with:
Joon H. Uhm United States
Yukihiko Sonoda Japan
Joerg‐Christian Tonn Germany
M. Kelly Nicholas United States
Andreas Waha Germany
Akitake Mukasa Japan
Keishi Makino Japan
Mathilde C.M. Kouwenhoven Netherlands
Yoshitaka Narita Japan
Giulio Maira Italy
Marica Eoli relative to Joon H. Uhm United States Joon H. Uhm's profile →
Citations per field
00.5×1.7×
Joon H. Uhm · 1×
Citations per year

Countries citing papers authored by Marica Eoli

Since Specialization
Citations

This map shows the geographic impact of Marica Eoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marica Eoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marica Eoli more than expected).

Fields of papers citing papers by Marica Eoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marica Eoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marica Eoli. The network helps show where Marica Eoli may publish in the future.

Co-authors

The 25 scholars most cited alongside Marica Eoli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marica Eoli Line = papers co-authored together Marica Eoli links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20234
3 20221
4 20223
5 20228
6 202213
7 20211
8 202028
9 20208
10 201928
11 2017168
12 20173
13 2014120
14 200634
15 200515
16 200465
17 200458
18 199921
19 19947
20 198910

About Marica Eoli

Marica Eoli is a scholar working on Genetics, Neurology, Cancer Research, Pathology and Forensic Medicine and Structural Biology, having authored 152 papers that have together received 3.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (86 papers), Brain Metastases and Treatment (24 papers), Multiple Sclerosis Research Studies (23 papers), Neurofibromatosis and Schwannoma Cases (21 papers), Meningioma and schwannoma management (15 papers), Immunotherapy and Immune Responses (14 papers), Radiomics and Machine Learning in Medical Imaging (12 papers) and Cancer, Hypoxia, and Metabolism (12 papers). The work is most often cited by research in Genetics (2.0k citations), Cancer Research (766 citations), Neurology (618 citations), Pathology and Forensic Medicine (574 citations) and Oncology (693 citations). Marica Eoli has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Andrea Salmaggi, Gaetano Finocchiaro, Giovanni Broggi, Bianca Pollo, Antonio Silvani, L. La Mantia, A. Boiardi, Elena Anghileri, C. Milanese and Francesco Acerbi. Their work appears in journals such as Journal of Neuro-Oncology, Neuro-Oncology, Journal of Clinical Oncology, Neurological Sciences and Journal of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026